Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence
Related Experiment Video
Updated: Oct 9, 2026

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
A Carlsson1, N Waters, S Holm-Waters
1Institute of Physiology and Pharmacology, University of Göteborg, Göteborg, Sweden. arvid.carlsson@pharm.gu.se
Abstract:
In spite of its proven heuristic value, the dopamine hypothesis of schizophrenia is now yielding to a multifactorial view, in which the other monoamines as well as glutamate and GABA are included, with a focus on neurotransmitter interactions in complex neurocircuits. The primary lesion(s) in schizophrenia does not necessarily involve any of these neurotransmitters directly but could deal with a more general defect, such as a faulty connectivity of developmental origin. Nevertheless, a precise identification of neurotransmitter aberrations in schizophrenia will probably provide clues for a better understanding of the disease and for the development of new treatment and prevention strategies.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Antiepileptic Drugs: Glutamate Antagonists
Excitatory and Inhibitory Effects of Neurotransmitters
Antidepressant Drugs: MAOIs and Other Agents
G Protein-coupled Receptors
